GnRH agonist: Increasing the pregnancy rate after combined treatment with hMG/hCG and direct intraperitoneal insemination

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 44, Issue 1, 1999, Pages 18-22

  Minoura, Hiroyuki ^a   Takeuchi, Shigeto ^b   Shen, Xiaoxiong ^b   Shibahara, Takashi ^b   Futamura, Noritaka ^b   Toyoda, Nagayasu ^b  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Controlled ovarian hyperstimulation; Direct intraperitoneal insemination; GnRH; GnRH agonist; Infertility

Indexed keywords

BUSERELIN ACETATE; CHORIONIC GONADOTROPIN; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN;

ADULT; ARTICLE; ARTIFICIAL INSEMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPEROVULATION;

ADULT; BUSERELIN; CHORIONIC GONADOTROPIN; ESTRADIOL; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFERTILITY, FEMALE; INSEMINATION, ARTIFICIAL; LUTEINIZING HORMONE; MENOTROPINS; PREGNANCY; PREGNANCY RATE; PROGESTERONE; PROSPECTIVE STUDIES;

EID: 0032929141     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Forrler A, Dellenbach P, Nisand I: Direct intraperitoneal insemination in unexplained and cervical infertility. Lancet 1986; 916-922
2. Barciulli F, Ricci G, Levi D'Ancona R: Our experience with direct intraperitoneal insemination (DIPI) as a treatment for infertile couples. Acta Eur Fertil 1990; 21:251-256
3. Ragni G, Lombroso GC, De Lauretis L: Pregnancy after direct intraperitoneal insemination of spermatozoa from a man with severe infertility, after unsuccessful application of other methods of assisted fertilization. Hum Reprod 1990;5: 225-226
4. Seracchioli R, Melega C, Maccolini A: Pregnancy after direct intraperitoneal insemination. Hum Reprod 1991;6:533-536
5. Dooley M, Lim-Howe D, Savvas M, et al: Early experience with gamete intrafallopian transfer (GIFT) and direct intraperitoneal insemination (DIPI). J R Soc Med 1988;81: 637-639
6. Abyholm T, Tanbo T, Dale PO, et al: In vivo fertilization procedures in infertile women with patent fallopian tubes: A comparison of gamete intrafallopian transfer, combined intrauterine and intraperitoneal insemination, and controlled ovarian hyperstimulation alone. J Assoc Reprod Genet 1992; 9:19-23
7. Stanger JD, Yovich JL: Reduced in vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during follicular phase. Br J Obstet Gynaecol 1985;92:385-393
8. Dodson WC, Hughes LC Jr, Yancy SE, et al: Clinical characteristics of ovulation induction with human menopausal gonadotropins with and without leuproride acetate in polycysric ovary syndrome. Fertil Steril 1989;52:912-918
9. Fleming R, Coutts JRT: Induction of multiple follicular growth in normally menstruating women with endogeneous gonadotropin suppression. Fertil Steril 1986;45:226-230
10. Kubik CJ, Guzick DS, Berga SL, et al: Randomized, prospective trial of leuprolide acetate and conventional superovulation in first cycles of in vitro fertilization and gamete intrafallopian transfer. Fertil Steril 1990;54:836-841
11. Kingsland C, Tan SL, Bickerton N, et al: The routine use of gonadotropin releasing hormone agonists for all patients undergoing in vitro fertilization: Is there any medical advantage?: A prospective randomized study. Fertil Steril 1992; 57:804-809
12. Pehninger S, Toner JP, Veeck LL, et al: Performance of cryopreserved pre-embryos obtained in in vitro fertilization cycles with or without a gonadotropin releasing hormone agonist. Fertil Steril 1992;7:620-625
13. Gagliardi CL, Emmi AM, Weiss G, et al: Gonadotropin-releasing hormone agonist improves the efficiency of controlled ovarian hyperstimulation/intrauterine insemination. Fertil Steril 1991;55:939-944
14. Under C, Braendle W, Lichtenberg V, Kohler S, Bettendorf G: Ovarian response and pregnancy rates in in vitro fertilization, gamete intrafallopian transfer, and in vivo fertilization therapies after combined gonadotropin releasing hormone agonist/human menopausal gonadotropin stimulation. Gynecol Obstet Invest 1990;29:140-144
15. Dodson WC, Walmer DK, Hughes CL Jr, et al: Adjunctive leuprolide therapy dose not improve cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination of subfertile women. Obstet Gynecol 1991;78: 187-190
16. Hofmann GE, Bergh PA, Guzman I, et al: Premature luteinization is not eliminated by pituitary desensitization with leuprolide acetate in women undergoing gonadotrophin stimulation who demonstrated premature luteinization in a prior gonadotrophin-only cycle. Hum Reprod 1993;8:695-698
17. Hofmann GE, Khoury J, Johnson CA, et al: Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact on pregnancy outcome. Fertil Steril 1996;66:980-986
18. Ubaldi F, Camus M, Smitz J, et al: Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH. 1996; 66:275-280